Piribo: Financial Markets Research: Palatin Technologies
PRWeb - Palatin Technologies’ bremelanotide (PT-141) is a novel melanocortin receptor agonist that is believed to be the only agent currently in development for the treatment of both erectile dysfunction (ED) and female sexual dysfunction (FSD). Highlights
Source: www.prweb.com
Men With ED Favor Treatment With Vardenafil
eMaxHealth.com - Vardenafil and Erectile Dysfunction Treatment Research published in The Journal of Sexual Medicine and presented at the 12th World Congress of the International Society for Sexual Medicine in Cairo, Egypt is unique in that the data is from a head to
Source: www.emaxhealth.com

